Sanofi News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

16.03.16	Sanofi, DiCE Molecules To Collaborate To Discover Potential Therapeutics (RTTNews)
16.03.16	Sanofi and DiCE Molecules Announce Research Collaboration to Discover Potential Therapeutics Based on Unique Small Molecule Discovery Platform (GlobeNewswire)
11.03.16	Regeneron: Sarilumab Shows Stronger Efficacy Than Adalimumab In Phase 3 Study (RTTNews)
11.03.16	Sanofi and Regeneron Announce Topline Results of Phase 3 Monotherapy Study Demonstrating Superiority of Sarilumab vs. Adalimumab in Patients with Active Rheumatoid Arthritis (GlobeNewswire)
10.03.16	Sanofi Appoints Dr. Ameet Nathwani to Executive Committee and Executive Vice President, Group Chief Medical Officer (GlobeNewswire)
08.03.16	Sanofi Pasteur, Merck To End Joint Vaccines Operations In Europe - Quick Facts (RTTNews)
08.03.16	Sanofi Pasteur and MSD (Known as Merck in the United States and Canada) Announce Intent to End Joint Vaccines Operations in Europe, Sanofi Pasteur MSD, to Pursue Their Own Distinct Growth Strategies (GlobeNewswire)
04.03.16	Sanofi: Filing of the 2015 U.S. Form 20-F and French "Document de Référence" containing the Annual Financial Report (GlobeNewswire)
03.03.16	Sanofi Genzyme Presents Results from Phase 1/2 Study of Investigational Second-Generation Therapy for Pompe Disease (GlobeNewswire)
03.03.16	Sanofi Genzyme Presents Results from Phase 1/2 Study of Investigational Second-Generation Therapy for Pompe Disease (Businesswire)
03.03.16	Sanofi's Board of Directors Proposes Appointment of Diane Souza and Thomas Südhof, MD as New Independent Directors (GlobeNewswire)
02.03.16	Actress Madeleine Stowe and Sanofi Genzyme Launch New Phase of Take Action on MS with Dynamic Webisode Series (Businesswire)
22.02.16	FDA Accepts Sanofi NDA On Glargine And Lixisenatide (RTTNews)
22.02.16	FDA Accepts Sanofi New Drug Application for Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide (GlobeNewswire)
09.02.16	Sanofi Q4 Profit Falls; Expects 2016 Business EPS To Be Broadly Stable At CER (RTTNews)
05.02.16	Sanofi Appoints Muzammil Mansuri to Executive Committee and Executive Vice President, Strategy & Business Development (GlobeNewswire)
02.02.16	Sanofi Pasteur Launches Zika Vaccine Project - Quick Facts (RTTNews)
02.02.16	Sanofi Pasteur to leverage its strong vaccine legacy in hunt for Zika vaccine (GlobeNewswire)
28.01.16	Sanofi and the Iran Ministry of Health and Medical Education Sign a Memorandum of Cooperation (GlobeNewswire)
14.01.16	Sanofi Pasteur Signs Deal To Partially Fund Human Vaccines Project - Quick Facts (RTTNews)
14.01.16	Sanofi Pasteur Provides Key Support to the Human Vaccines Project (GlobeNewswire)
11.01.16	Sanofi, Warp Drive Bio In Deal To Develop Oncology Therapies And Antibiotics (RTTNews)
11.01.16	Sanofi and Warp Drive Bio to Collaborate on the Development of Novel Oncology Therapies and Antibiotics Based on Proprietary Platforms (GlobeNewswire)
11.01.16	Sanofi, Innate Pharma Collaborate On New Bispecific NK Cell Engagers (RTTNews)
11.01.16	Sanofi and Innate Pharma Collaborate on New Bispecific NK Cell Engagers in Immuno-Oncology (GlobeNewswire)
08.01.16	Regeneron, Sanofi: FDA Accepts Sarilumab BLA For Review - Quick Facts (RTTNews)
08.01.16	Sanofi and Regeneron Announce Sarilumab Biologics License Application Accepted for Review by US FDA (GlobeNewswire)
05.01.16	Global Genomics Partners With Sanofi To Find Out Etiology Of Cornonary Diseases (RTTNews)
05.01.16	MannKind Terminates License Deal With Sanofi For Afrezza Inhalation Powder (RTTNews)
28.12.15	Sanofi Pasteur Announces Approval Of Dengvaxia In Brazil - Quick Facts (RTTNews)
28.12.15	Dengvaxia® First Dengue Vaccine Approved in Brazil (GlobeNewswire)
23.12.15	Zealand: Sanofi Submits NDA For LixiLan - Quick Facts (RTTNews)
23.12.15	Sanofi Submits New Drug Application for the Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide (GlobeNewswire)
22.12.15	Sanofi's Dengue Vaccine Approved In Philippines (RTTNews)
22.12.15	Sanofi Pasteur's Dengue Vaccine Approved in the Philippines (GlobeNewswire)
15.12.15	Sanofi & Boehringer Ingelheim In Negotiations To Swap Businesses - Quick Facts (RTTNews)
15.12.15	Sanofi and Boehringer Ingelheim Enter Exclusive Negotiations on Business Swap : Sanofi Would Become a Global Leader in Consumer Healthcare and Boehringer Ingelheim Would Become Second largest Anima... (GlobeNewswire)
11.12.15	Regeneron, Sanofi: UnitedHealth Selects Praluent Injection For Preferred Access (RTTNews)
09.12.15	Sanofi: Dengvaxia®, World's First Dengue Vaccine, Approved in Mexico (GlobeNewswire)
01.12.15	Sanofi Launches New Priftin Packaging For Latent And Active Tuberculosis (RTTNews)
30.11.15	Sanofi: First Doses of Injectable Polio Vaccine ShanIPV(TM) Soon Available for Indian Infants (GlobeNewswire)
24.11.15	Regeneron, Sanofi Fully Enroll ODYSSEY OUTCOMES Trial Of Praluent Injection (RTTNews)
24.11.15	Sanofi and Regeneron Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® (alirocumab) Injection Fully Enrolled (GlobeNewswire)
20.11.15	Sanofi, AstraZeneca Exchange More Than 200,000 Chemical Compounds - Quick Facts (RTTNews)
20.11.15	Sanofi and AstraZeneca Exchange More Than 200,000 Chemical Compounds (GlobeNewswire)
18.11.15	Sanofi Names Xavier Darcos As President Of Sanofi Espoir Foundation (RTTNews)
18.11.15	Xavier Darcos appointed President of the Sanofi Espoir Foundation (GlobeNewswire)
09.11.15	Sanofi Pasteur Reveals its Research on a "Universal" Influenza Vaccine (GlobeNewswire)
08.11.15	Sanofi, Regeneron Announce Sarilumab Phase 3 Study Meets Co-primary End Point (RTTNews)
08.11.15	Sanofi and Regeneron Present Results from Pivotal Phase 3 Study of Sarilumab at American College of Rheumatology Annual Meeting (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		SPI-Handel aktuell: SPI zum Handelsende leichter
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter
20.12.24		Handel in Europa: STOXX 50 schliesst im Minus
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

SPI-Handel aktuell: SPI zum Handelsende leichter

20.12.24

Verluste in Europa: Euro STOXX 50 letztendlich leichter

20.12.24

Handel in Europa: STOXX 50 schliesst im Minus